Your trusted partner in biologics and ADC development and manufacturing

About MabPlex

MabPlex provides global CDMO services in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs and bispecifics. We offer our partners contract services from DNA to finished drug product. Our technical expertise allows us to provide effective high quality solutions for our partners biomanufacturing needs. At both our US R&D site and our manufacturing site in Yantai, China, MabPlex delivers our commitment to our partners through our quality manufacturing, meeting their expectations.

  • Comprehensive biologics development and manufacturing solutions for customers globally
  • Multiple Single Use 2000L Bioreactors for GMP Manufacturing
  • One of the few providers of large-scale ADC production worldwide
  • Services for pre-clinical studies through commercial production
  • Senior Management Team averaging over 20 years of industry experience globally

MISSION

MabPlex strives to be the world leader in providing CRO/CDO services enabling our clients to deliver top quality biopharmaceuticals to patients globally.

CUSTOMER FOCUSED

At MabPlex, we believe that our customers are the foundation of our business. We view you not just as customers, but rather as our partners. This is reflected in all parts of our company. Our quality by design approach puts our partners first by ensuring that the project is done correctly and with traceability. We deliver as promised on time at top quality. With this, we believe that the key to our success it to create long-term relationships.

Professional Integrity

From discussing your project to the final product we keep our partners in mind. All information is kept secure and confidential at every step. Our thoughts are, “how would we like to be dealt with if we were the customer?” We conduct ourselves with honesty in all of our dealings with partners, employees, and the community. Therefore, we deliver on time, quality, and best in value.

Service Excellence

Service excellence is reflected in how everyone at MabPlex thinks and acts. From your first interaction with us, you will see us promptly respond, provide consistent communication throughout your project, and a focus on providing a superior experience each and every time. Our quality culture is what drives our commitment to our partners and their biopharmaceuticals.

Our JOURNEY

June 2013
June 2013

MabPlex International, Ltd. was established.

previous arrow
next arrow

LOCATIONS

MabPlex is headquartered in Yantai Economic and Development Area, a city in the northeast of the Shandong Province. It is bordered by both the Yellow Sea and the Bohai Sea. YEDA, Yantai Economic and Development Area, is one of the first 14 state-level development zones approved by the State Council of China in 1984. Yantai has attracted investments from more than 40 countries and regions, and more than 80 Fortune 500 Companies.

The biopharmaceutical industry in Yantai has prospered in the last two years. The number of biopharmaceutical corporations has reached 100, in which 13 companies have gone public in domestic and abroad market. In 2018, the total income of Yantai biopharmaceutical was 11 billion U.S dollars, with a year-on-year growth of 13.3%.

Yantai is also a tourist attraction.

SAN DIEGO